Search research articles
Contact Us
Filters
Showing results (361-370 of 385) with videos related to
Page
of 39
Sort By:
Pharmacopsychiatry
|
June 25, 2024
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study
Farhana Islam, Amanda Lisoway, Edward S Oh, et al.
Bipolar Disorders
|
July 10, 2026
Establishing a Specialty Bipolar Clinic: The National Network of Depression Centers Consensus Recommendations
Christopher D Schneck, Jorge R C Almeida, David J Bond, et al.
Bipolar Disorders
|
October 2, 2021
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations
Lakshmi N Yatham, Trisha Chakrabarty, David J Bond, et al.
Bipolar Disorders
|
March 15, 2018
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.
Innovations in Clinical Neuroscience
|
February 1, 2021
THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial
Anthony L Vaccarino, Amir H Kalali, Pierre Blier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2020
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
Yemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, et al.
JMIR Formative Research
|
January 24, 2024
Correction: Evaluating the Clinical Feasibility of an Artificial Intelligence-Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility Study
Christina Popescu, Grace Golden, David Benrimoh, et al.
JMIR Formative Research
|
October 25, 2021
Evaluating the Clinical Feasibility of an Artificial Intelligence-Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility Study
Christina Popescu, Grace Golden, David Benrimoh, et al.
Bjpsych Open
|
January 6, 2021
Using a simulation centre to evaluate preliminary acceptability and impact of an artificial intelligence-powered clinical decision support system for depression treatment on the physician-patient interaction
David Benrimoh, Myriam Tanguay-Sela, Kelly Perlman, et al.
Clinical Pharmacology and Therapeutics
|
January 22, 2023
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study
Leen Magarbeh, Claudia Hassel, Maximilian Choi, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 385) with videos related to
Sort By:
Page
of 39
Pharmacopsychiatry
|
June 25, 2024
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study
Farhana Islam, Amanda Lisoway, Edward S Oh, et al.
Bipolar Disorders
|
July 10, 2026
Establishing a Specialty Bipolar Clinic: The National Network of Depression Centers Consensus Recommendations
Christopher D Schneck, Jorge R C Almeida, David J Bond, et al.
Bipolar Disorders
|
October 2, 2021
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations
Lakshmi N Yatham, Trisha Chakrabarty, David J Bond, et al.
Bipolar Disorders
|
March 15, 2018
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.
Innovations in Clinical Neuroscience
|
February 1, 2021
THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial
Anthony L Vaccarino, Amir H Kalali, Pierre Blier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2020
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
Yemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, et al.
JMIR Formative Research
|
January 24, 2024
Correction: Evaluating the Clinical Feasibility of an Artificial Intelligence-Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility Study
Christina Popescu, Grace Golden, David Benrimoh, et al.
JMIR Formative Research
|
October 25, 2021
Evaluating the Clinical Feasibility of an Artificial Intelligence-Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility Study
Christina Popescu, Grace Golden, David Benrimoh, et al.
Bjpsych Open
|
January 6, 2021
Using a simulation centre to evaluate preliminary acceptability and impact of an artificial intelligence-powered clinical decision support system for depression treatment on the physician-patient interaction
David Benrimoh, Myriam Tanguay-Sela, Kelly Perlman, et al.
Clinical Pharmacology and Therapeutics
|
January 22, 2023
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study
Leen Magarbeh, Claudia Hassel, Maximilian Choi, et al.
Page
of 39